Condition Location Conditions Locations Treatment Type Trial Phase Trial Status Paid Participation Trial Details Key Eligibility Criteria 434 Participants Needed Trial Details Key Eligibility Criteria 900 Participants Needed Trial Details Key Eligibility Criteria 200 Participants Needed Trial Details Key Eligibility Criteria 330 Participants Needed Trial Details Key Eligibility Criteria 450 Participants Needed Trial Details Key Eligibility Criteria 142 Participants Needed Trial Details Key Eligibility Criteria 50 Participants Needed Trial Details Key Eligibility Criteria 64 Participants Needed Trial Details Key Eligibility Criteria 15 Participants Needed Trial Details Key Eligibility Criteria 164 Participants Needed Trial Details Key Eligibility Criteria 325 Participants Needed Trial Details Key Eligibility Criteria 900 Participants Needed Trial Details Key Eligibility Criteria 456 Participants Needed Trial Details Key Eligibility Criteria 300 Participants Needed Trial Details Key Eligibility Criteria 30 Participants Needed Trial Details Key Eligibility Criteria 162 Participants Needed Trial Details Key Eligibility Criteria 400 Participants Needed Trial Details Key Eligibility Criteria 443 Participants Needed Trial Details Key Eligibility Criteria 110 Participants Needed Trial Details Key Eligibility Criteria 2099 Participants Needed "As a healthy volunteer, I like to participate in as many trials as I'm able to

However, all these options require prescription injections, and many individuals do not meet the qualifying criteria
For best results, pair with a protein shake or meal containing 20-30g of protein
You can store them at room temperature and carry them during travel without any additional considerations or effort
Key Steps in Lipedema Diagnosis: Clinical Examination & Symptom Evaluation Lipedema is identified by its characteristic column-like fat distribution, especially in the legs, which remains disproportionate to the upper body
Use probiotics strategically Choose probiotic products that have shown metabolic benefit in human clinical trials